ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding ClearPoint Neuro, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 89 | 101 | +12 |
| Shares | 7.60M | 8.19M | +587.7K (+7.7%) |
| Value | $117.0M | $97.5M | −$19.5M (−16.6%) |
New holders (23)
Institutions that held ClearPoint Neuro, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (11)
Institutions that held ClearPoint Neuro, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Invesco Ltd. | 247,977 | $3.81M |
| 683 Capital Management, LLC | 54,387 | $836.5K |
| Connor, Clark & Lunn Investment Management Ltd. | 21,396 | $329.1K |
| GWM Advisors LLC | 21,114 | $324.7K |
| Aster Capital Management (DIFC) Ltd | 17,500 | $269.1K |
| XTX Topco Ltd | 14,339 | $220.5K |
| Two Sigma Investments, LP | 10,314 | $158.6K |
| Occudo Quantitative Strategies LP | 10,109 | $155.5K |
| Oarsman Capital, Inc. | 5,000 | $76.9K |
| R Squared Ltd | 2,050 | $31.5K |
| POM Investment Strategies, LLC | 15 | $231 |